AIDS groups push firm on Viraday price cut
15th Nov 2006, 04:15 GMT
Officials from a global chain of AIDS clinics Tuesday pressured Indian generic firm Cipla to lower the price of AIDS drug Viraday.
AIDS groups push firm on Viraday price cut related news:
- Burundi: Food Cuts for HIV-Positive People Worry NGOs — AllAfrica News: HIV-Aids and STDs
- Botswana: Bonela Press Forward With Quest for Aids Law — AllAfrica News: HIV-Aids and STDs
- WitsView street price trend update: Prices keep dropping — DigiTimes: IT news from Asia
- Uganda: HIV/Aids Song Released — AllAfrica News: HIV-Aids and STDs
- Clariant to cut 10% of workforce — BBC News | Business | Companies | UK Edition
- Africa: Africa to Get Lion's Share of Sh43b for Aids and Malaria — AllAfrica News: HIV-Aids and STDs
- Understanding the Scourge of HIV-AIDS in Sub-Saharan Africa — Medscape Hiv-Aids Headlines
- South Africa: State Claims Half of Those in Need Now On Aids Drugs — AllAfrica News: HIV-Aids and STDs
- Cabinet cancels Falash Mura aliya cut — JPost.com Jewish News
- Mozambique: Guebuza Warns Frelimo Congress on Aids — AllAfrica News: HIV-Aids and STDs
Latest news from United Press International - Health Business:
- AmerisourceBergen tests Rx tracking plan
- Lilly: Arxxant cuts sight loss in diabetes
- Merck: Arcoxia heart risk same as Voltaren
- Corcept tests psych. major depression Rx
- Neurogen's obesity drug in phase 1 trial
- Analysis: Insurance horizons expanding
- Dendreon seeks OK for Provenge
- Robots caring for stroke patients
- Diabetes drug stalls heart disease
- Diabetes drug also helps arteries